Toshiba has announced that it has developed a blood test that can detect several cancers with 99 percent accuracy in just hours.
The Japanese firm teamed up with Tokyo Medical University and the National Cancer Center to develop the technology.
Toshiba scientists say the test measures the concentration of microRNA molecules released by cancer cells. They say it can detect 13 types of cancer in early stages, including pancreatic, stomach, and breast cancers.
The researchers say the tests are run through a small device that can identify the disease within two hours. They believe it could reduce the cost of cancer screening.
Toshiba plans to conduct further testing with the aim of commercializing the technology within a few years.